2024亞太區美容展參展商名錄

Founded in 2019, Wellpharmtech has quickly become a leader in the non-reimbursable medication market with products like glutathione and Cindella injections. Drawing on extensive pharmaceutical R&D expertise, the company expanded into cosmeceuticals with its Dermagen brand, rapidly growing through partnerships with over 2,000 korean clinics and hospitals. To reach a broader audience, Wellpharmtech launched Rapporapy, a B2C brand, offering its high-quality products directly to consumers. Today, Wellpharmtech aims to be a global pharmaceutical leader, with a diverse portfolio that includes non-reimbursable and prescription medications, medical devices, and cosmeceutical products. The company has successfully extended its reach to nearly 50 countries, reflecting its commitment to innovation and global health improvement.